List of Tables
Table 1. Blood Derivative Product Market Trends
Table 2. Blood Derivative Product Market Drivers & Opportunity
Table 3. Blood Derivative Product Market Challenges
Table 4. Blood Derivative Product Market Restraints
Table 5. Global Blood Derivative Product Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Blood Derivative Product Revenue Market Share by Company (2019-2024)
Table 7. Global Blood Derivative Product Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Blood Derivative Product Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Blood Derivative Product Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Blood Derivative Product Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Blood Derivative Product Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Blood Derivative Product
Table 13. Global Blood Derivative Product Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Derivative Product as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Blood Derivative Product Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Blood Derivative Product Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Blood Derivative Product Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Blood Derivative Product Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Blood Derivative Product Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Blood Derivative Product Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Blood Derivative Product Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Blood Derivative Product Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Blood Derivative Product Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Blood Derivative Product Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Blood Derivative Product Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Blood Derivative Product Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Blood Derivative Product Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Blood Derivative Product Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Blood Derivative Product Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Blood Derivative Product Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Blood Derivative Product Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Blood Derivative Product Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Blood Derivative Product Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Blood Derivative Product Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Blood Derivative Product Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Blood Derivative Product Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Blood Derivative Product Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Blood Derivative Product Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Blood Derivative Product Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Blood Derivative Product Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Blood Derivative Product Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Blood Derivative Product Sales Value by Region (2019-2024) & (%)
Table 44. Global Blood Derivative Product Sales Value by Region (2025-2030) & (%)
Table 45. Global Blood Derivative Product Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Blood Derivative Product Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Blood Derivative Product Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Blood Derivative Product Sales Volume by Region (2019-2024) & (%)
Table 49. Global Blood Derivative Product Sales Volume by Region (2025-2030) & (%)
Table 50. Global Blood Derivative Product Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Blood Derivative Product Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Blood Derivative Product Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Blood Derivative Product Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Blood Derivative Product Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Blood Derivative Product Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Blood Derivative Product Sales Volume, (2025-2030) & (K Units)
Table 57. GlaxoSmithKline Company Information
Table 58. GlaxoSmithKline Introduction and Business Overview
Table 59. GlaxoSmithKline Blood Derivative Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. GlaxoSmithKline Blood Derivative Product Product Offerings
Table 61. GlaxoSmithKline Recent Development
Table 62. Pfizer, Inc Company Information
Table 63. Pfizer, Inc Introduction and Business Overview
Table 64. Pfizer, Inc Blood Derivative Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Pfizer, Inc Blood Derivative Product Product Offerings
Table 66. Pfizer, Inc Recent Development
Table 67. Bristol-Myers Squibb Company Company Information
Table 68. Bristol-Myers Squibb Company Introduction and Business Overview
Table 69. Bristol-Myers Squibb Company Blood Derivative Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Bristol-Myers Squibb Company Blood Derivative Product Product Offerings
Table 71. Bristol-Myers Squibb Company Recent Development
Table 72. Leo Pharma A/S Company Information
Table 73. Leo Pharma A/S Introduction and Business Overview
Table 74. Leo Pharma A/S Blood Derivative Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Leo Pharma A/S Blood Derivative Product Product Offerings
Table 76. Leo Pharma A/S Recent Development
Table 77. Sanofi Company Information
Table 78. Sanofi Introduction and Business Overview
Table 79. Sanofi Blood Derivative Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Sanofi Blood Derivative Product Product Offerings
Table 81. Sanofi Recent Development
Table 82. Fusion Health Care Company Information
Table 83. Fusion Health Care Introduction and Business Overview
Table 84. Fusion Health Care Blood Derivative Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Fusion Health Care Blood Derivative Product Product Offerings
Table 86. Fusion Health Care Recent Development
Table 87. AstraZeneca Plc Company Information
Table 88. AstraZeneca Plc Introduction and Business Overview
Table 89. AstraZeneca Plc Blood Derivative Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. AstraZeneca Plc Blood Derivative Product Product Offerings
Table 91. AstraZeneca Plc Recent Development
Table 92. Baxter International Inc Company Information
Table 93. Baxter International Inc Introduction and Business Overview
Table 94. Baxter International Inc Blood Derivative Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Baxter International Inc Blood Derivative Product Product Offerings
Table 96. Baxter International Inc Recent Development
Table 97. BDI Pharma Company Information
Table 98. BDI Pharma Introduction and Business Overview
Table 99. BDI Pharma Blood Derivative Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. BDI Pharma Blood Derivative Product Product Offerings
Table 101. BDI Pharma Recent Development
Table 102. SK Plasma Company Information
Table 103. SK Plasma Introduction and Business Overview
Table 104. SK Plasma Blood Derivative Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. SK Plasma Blood Derivative Product Product Offerings
Table 106. SK Plasma Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Blood Derivative Product Downstream Customers
Table 110. Blood Derivative Product Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Blood Derivative Product Product Picture
Figure 2. Global Blood Derivative Product Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Blood Derivative Product Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Blood Derivative Product Sales Volume (2019-2030) & (K Units)
Figure 5. Global Blood Derivative Product Sales Price (2019-2030) & (US$/Unit)
Figure 6. Blood Derivative Product Report Years Considered
Figure 7. Global Blood Derivative Product Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Blood Derivative Product Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Blood Derivative Product Revenue in 2023
Figure 10. Blood Derivative Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Albumin Picture
Figure 12. Coagulation Factor Concentrates Picture
Figure 13. Immunoglobulins Picture
Figure 14. Other Picture
Figure 15. Global Blood Derivative Product Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Blood Derivative Product Sales Value Market Share by Type, 2023 & 2030
Figure 17. Global Blood Derivative Product Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 18. Global Blood Derivative Product Sales Volume Market Share by Type, 2023 & 2030
Figure 19. Global Blood Derivative Product Price by Type (2019-2030) & (US$/Unit)
Figure 20. Product Picture of Platelet Aggregation Inhibitors
Figure 21. Product Picture of Fibrinolytics
Figure 22. Product Picture of Anticoagulants
Figure 23. Product Picture of Other
Figure 24. Global Blood Derivative Product Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 25. Global Blood Derivative Product Sales Value Market Share by Application, 2023 & 2030
Figure 26. Global Blood Derivative Product Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 27. Global Blood Derivative Product Sales Volume Market Share by Application, 2023 & 2030
Figure 28. Global Blood Derivative Product Price by Application (2019-2030) & (US$/Unit)
Figure 29. North America Blood Derivative Product Sales Value (2019-2030) & (US$ Million)
Figure 30. North America Blood Derivative Product Sales Value by Country (%), 2023 VS 2030
Figure 31. Europe Blood Derivative Product Sales Value (2019-2030) & (US$ Million)
Figure 32. Europe Blood Derivative Product Sales Value by Country (%), 2023 VS 2030
Figure 33. Asia Pacific Blood Derivative Product Sales Value (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Blood Derivative Product Sales Value by Country (%), 2023 VS 2030
Figure 35. South America Blood Derivative Product Sales Value (2019-2030) & (US$ Million)
Figure 36. South America Blood Derivative Product Sales Value by Country (%), 2023 VS 2030
Figure 37. Middle East & Africa Blood Derivative Product Sales Value (2019-2030) & (US$ Million)
Figure 38. Middle East & Africa Blood Derivative Product Sales Value by Country (%), 2023 VS 2030
Figure 39. Key Countries/Regions Blood Derivative Product Sales Value (%), (2019-2030)
Figure 40. Key Countries/Regions Blood Derivative Product Sales Volume (%), (2019-2030)
Figure 41. United States Blood Derivative Product Sales Value, (2019-2030) & (US$ Million)
Figure 42. United States Blood Derivative Product Sales Value by Type (%), 2023 VS 2030
Figure 43. United States Blood Derivative Product Sales Value by Application (%), 2023 VS 2030
Figure 44. Europe Blood Derivative Product Sales Value, (2019-2030) & (US$ Million)
Figure 45. Europe Blood Derivative Product Sales Value by Type (%), 2023 VS 2030
Figure 46. Europe Blood Derivative Product Sales Value by Application (%), 2023 VS 2030
Figure 47. China Blood Derivative Product Sales Value, (2019-2030) & (US$ Million)
Figure 48. China Blood Derivative Product Sales Value by Type (%), 2023 VS 2030
Figure 49. China Blood Derivative Product Sales Value by Application (%), 2023 VS 2030
Figure 50. Japan Blood Derivative Product Sales Value, (2019-2030) & (US$ Million)
Figure 51. Japan Blood Derivative Product Sales Value by Type (%), 2023 VS 2030
Figure 52. Japan Blood Derivative Product Sales Value by Application (%), 2023 VS 2030
Figure 53. South Korea Blood Derivative Product Sales Value, (2019-2030) & (US$ Million)
Figure 54. South Korea Blood Derivative Product Sales Value by Type (%), 2023 VS 2030
Figure 55. South Korea Blood Derivative Product Sales Value by Application (%), 2023 VS 2030
Figure 56. Southeast Asia Blood Derivative Product Sales Value, (2019-2030) & (US$ Million)
Figure 57. Southeast Asia Blood Derivative Product Sales Value by Type (%), 2023 VS 2030
Figure 58. Southeast Asia Blood Derivative Product Sales Value by Application (%), 2023 VS 2030
Figure 59. India Blood Derivative Product Sales Value, (2019-2030) & (US$ Million)
Figure 60. India Blood Derivative Product Sales Value by Type (%), 2023 VS 2030
Figure 61. India Blood Derivative Product Sales Value by Application (%), 2023 VS 2030
Figure 62. Blood Derivative Product Industrial Chain
Figure 63. Blood Derivative Product Manufacturing Cost Structure
Figure 64. Channels of Distribution (Direct Sales, and Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
